Pediatric Nephrology

, Volume 1, Issue 2, pp 183–194 | Cite as

A review of drug prescribing in children with end-stage renal failure

  • Richard S. Trompeter
Practical Pediatric Nephrology

Abstract

This review provides a guideline for the prescribing of drugs in children with end-stage renal failure. The altered physiology of renal failure affects the metabolism of most pharmacological agents and modification of the drug dosage or extension of the prescribed drug interval become necessary with declining glomerular filtration rate (GFR). Most dose adjustments are dependent on a knowledge of renal function since GFR is inversely proportioned to the elimination rate constant of a drug. The details of drugs listed by generic name are those commonly used in paediatric practice, and the recommendations for dose adjustments are related to a reduction in GFR and not to body mass. Familiarisation with the normal dose prescription of any drug used in paediatric practice is therefore necessary when referring to the table.

Key words

Drug prescribing Pharmacokinetics End-stage renal failure 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Brater DC, Chennavasin P (1985) Effects of renal disease: pharmacokinetic considerations. In: Benet LZ, Massoud N, Gambertoglio JG (eds) Pharmacokinetic bases for drug treatment. Raven Press, New York. pp 119–147Google Scholar
  2. 2.
    Bennett WM (1984) Altering drug dose in patients with diseases of kidney and liver, In: Anderson RJ, Schrier RW (eds) Clinical use of drugs in patients with kidney and liver disease. WB. Saunders, Philadelphia, pp 16–29Google Scholar
  3. 3.
    Schwartz GJ, Haycock GB, Spitzer A (1976) Plasma creatinine and urea concentration in children: normal values for age and sex. J Pediatr 88:828–830PubMedGoogle Scholar
  4. 4.
    Schwartz GJ, Haycock GB, Edelmann NCM, Spitzer A (1976) A simple estimate of glomerular filtration rate derived from body and lenght plasma creatinine, Pediatrics 58: 259–263PubMedGoogle Scholar
  5. 5.
    Counahan R, Chantler C, Ghazali S, Kirkwood B, Rose F, Barratt TM (1976) Estimation of glomerular filtration rate form plasma creatinine concentration in children, Arch Dis Child 51: 875–878PubMedGoogle Scholar
  6. 6.
    Bennett WM, Plamp CE, Gilbert DN, Parker RA, Porter GA (1979) The influence of dosage regimen on experimental gentamicin nephrotoxicity: dissociation of peak serum levels from renal failure. J Infect Dis 140: 576–580PubMedGoogle Scholar
  7. 7.
    Gibson TP, Nelson HA (1977) Drug kinetics and artificial kidneys, Clin Pharmacolinet 2: 403–416Google Scholar
  8. 8.
    Gwilt PR, Perrier D (1978) Plasma protein binding and distribution characteristics of drugs as indices of their haemodializability. Clin Pharmacol Ther 24: 154–161PubMedGoogle Scholar
  9. 9.
    Somani P, Shapiro S, Stockard H, Higgins JT (1982) Unidirectional absorption of gentamicin from the peritoneum during continuous ambulatory peritoneal dialysis. Clin Pharmacol Ther 32: 113–121PubMedGoogle Scholar
  10. 10.
    Keating MJ, Bodley GP, Valdivraso M, Rodrigues V (1979) A randomised comparative trial of three aminoglycosides. Medicine 58: 159–170PubMedGoogle Scholar

Copyright information

© IPNA 1987

Authors and Affiliations

  • Richard S. Trompeter
    • 1
  1. 1.Department of PaediatricsRoyal Free HospitalLondonUK

Personalised recommendations